Merck: HPV vaccine for men approved in China
The U.S.-based pharmaceutical company reports that China's National Medical Products Administration (NMPA) has authorized the use of Gardasil in men aged 9 to 26 for the prevention of HPV-related diseases and cancers.
Gardasil thus becomes the first HPV vaccine for men approved in China.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction